Asymptomatic hyper-creatinephosphokinasemia: a veritable disease? Observation in some cases, Recenti Prog Med, vol.1, 2005. ,
Tumor Antigen Markers for the Detection of Solid Cancers in Inflammatory Myopathies, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.5, pp.1279-1282, 2005. ,
DOI : 10.1158/1055-9965.EPI-04-0624
Monoclonal antibody analysis of mononuclear cells in myoptahies ,
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis, Neurology, vol.63, issue.12, pp.2396-2404, 2004. ,
DOI : 10.1212/01.WNL.0000148588.15052.4C
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis, Neurology, vol.63, issue.12, pp.2396-2398, 2004. ,
DOI : 10.1212/01.WNL.0000148588.15052.4C
Dermatomyositis of Childhood, Journal of Neuropathology & Experimental Neurology, vol.34, issue.1, pp.46-75, 1975. ,
DOI : 10.1097/00005072-197501000-00005
Prognostic Factors and Predictive Signs of Malignancy in Adult Dermatomyositis, Archives of Dermatology, vol.126, issue.5, pp.633-637, 1990. ,
DOI : 10.1001/archderm.1990.01670290077012
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments., Journal of Clinical Investigation, vol.94, issue.5, pp.1729-1735, 1994. ,
DOI : 10.1172/JCI117520
Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases, Arthritis & Rheumatism, vol.4, issue.3, pp.249-55, 1985. ,
DOI : 10.1002/art.1780280303
Nouvelles classifications et??physiopathologie des??myopathies inflammatoires, La Revue de M??decine Interne, vol.28, issue.9, pp.603-612, 2007. ,
DOI : 10.1016/j.revmed.2007.03.004
Le muscle inflammatoire??: avanc??es en 2014, La Revue de M??decine Interne, vol.35, issue.7, pp.411-412, 2014. ,
DOI : 10.1016/j.revmed.2014.04.015
Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-351, 1975. ,
DOI : 10.1056/NEJM197502132920706
CYCLOPHOSPHAMIDE IN SEVERE POLYMYOSITIS, The Lancet, vol.333, issue.8647, pp.1138-1147, 1989. ,
DOI : 10.1016/S0140-6736(89)92416-1
Idiopathic inflammatory myopathies: Definition and management of refractory disease, Autoimmunity Reviews, vol.10, issue.11, pp.720-724, 2001. ,
DOI : 10.1016/j.autrev.2011.05.021
Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study, Annals of Internal Medicine, vol.134, issue.12, pp.1087-1095, 2001. ,
DOI : 10.7326/0003-4819-134-12-200106190-00008
Azathioprine with Prednisone for Polymyositis, Annals of Internal Medicine, vol.92, issue.3, pp.365-374, 1980. ,
DOI : 10.7326/0003-4819-92-3-365
Prednisone and azathioprine for polymyositis. Long-term followup, Arthritis & Rheumatism, vol.1, issue.1, pp.45-53, 1981. ,
DOI : 10.1002/art.1780240107
Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature, Clinical Rheumatology, vol.32, issue.Suppl 2, pp.1795-1801, 2007. ,
DOI : 10.1007/s10067-006-0526-5
Stratégies thérapeutiques dans les myopathies inflammatoires, Rev Med Suisse, vol.5, pp.812-818, 2009. ,
Muscle diseases in an internal medicine department, Rev Med Interne, vol.6, pp.429-463, 2004. ,
Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study, British Journal of Dermatology, vol.14, issue.344, pp.825-831, 2001. ,
DOI : 10.1097/00000421-199602000-00008
Plasma exchange in polymyositis and dermatomyositis : a multicenter study of 57 cases, Clin Exp Rheumatol, vol.13, pp.270-271, 1995. ,
The reply, The American Journal of Medicine, vol.93, issue.1, pp.114-115, 1992. ,
DOI : 10.1016/0002-9343(92)90699-C
Macrophagic myofasciitis, Current Rheumatology Reports, vol.121, issue.3, pp.483-492, 1999. ,
DOI : 10.1007/s11926-000-0079-6
Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11 cases, J ,
Contribution of tumour necrosis factor alpha and interleukin 1 ,
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis, Annals of the Rheumatic Diseases, vol.66, issue.10, pp.1345-1354, 2007. ,
DOI : 10.1136/ard.2006.068502
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry, Rheumatology, vol.50, issue.12, pp.2283-2292, 2011. ,
DOI : 10.1093/rheumatology/ker305
Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy, Archives of Dermatology, vol.126, issue.1, pp.61-65, 1990. ,
DOI : 10.1001/archderm.126.1.61
The failure of intravenous cyclophosphamide therapy in refractory idioptathic inflammatory myopathy, J Rheumatol, vol.16, pp.1225-1233, 1989. ,
Immunotherapy of myositis: issues, concerns and future prospects, Nature Reviews Rheumatology, vol.2, issue.3, pp.129-166, 2010. ,
DOI : 10.1038/nrrheum.2010.2
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis, New England Journal of Medicine, vol.325, issue.21, pp.1487-98, 1991. ,
DOI : 10.1056/NEJM199111213252107
Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategie ,
Polymyositis and dermatomyositis. The Lancet, pp.971-981, 2003. ,
Immunotherapy of myositis: issues, concerns and future prospects, Nature Reviews Rheumatology, vol.2, issue.3, pp.129-166, 2010. ,
DOI : 10.1038/nrrheum.2010.2
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis, New England Journal of Medicine, vol.329, issue.27 ,
DOI : 10.1056/NEJM199312303292704
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application, Autoimmunity Reviews, vol.10, issue.3, pp.144-153, 2011. ,
DOI : 10.1016/j.autrev.2010.09.004
Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features, Medicine, vol.83, issue.1, pp.35-42, 2004. ,
DOI : 10.1097/01.md.0000109755.65914.5e
Differential expression of chemokines in inflammatory myopathies, Neurology, vol.58, issue.12, pp.1779-85, 2002. ,
DOI : 10.1212/WNL.58.12.1779
Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies, Am J Pathol, vol.146, pp.1178-87, 1995. ,
Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis, J Rheumatol, vol.29, pp.1897-1906, 2002. ,
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases, European Journal of Neurology, vol.250, issue.Suppl. 1, pp.893-908, 2008. ,
DOI : 10.1111/j.1468-1331.2008.02246.x
Microvascular changes in early and advanced dermatomyositis: A quantitative study, Annals of Neurology, vol.23, issue.4, pp.343-56, 1990. ,
DOI : 10.1002/ana.410270402
Mononuclear cells in myopathies: Quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies, Human Pathology, vol.17, issue.7, pp.704-721, 1986. ,
DOI : 10.1016/S0046-8177(86)80180-0
Amyopathic dermatomyositis (dermatomyositis sin?? myositis), Journal of the American Academy of Dermatology, vol.24, issue.6 ,
DOI : 10.1016/0190-9622(91)70153-S
Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases, Rheumatology, vol.48, issue.9, pp.1166-1174, 2009. ,
DOI : 10.1093/rheumatology/kep147
Facteurs de pronostic et signes prédictifs de cancer au cours de la dermatomyosite de l'adulte, Ann Dermatol Vénéréol, vol.123, pp.722-726, 1996. ,
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay, Rheumatology, vol.49, issue.12 ,
DOI : 10.1093/rheumatology/keq281
Anti-Mi-2 antibodies, Autoimmunity, vol.5, issue.1, pp.79-83, 2005. ,
DOI : 10.1080/08916930400022681
Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis., Journal of Clinical Investigation, vol.97, issue.12, pp.2905-2910, 1996. ,
DOI : 10.1172/JCI118749
Interferon-??/??-mediated innate immune mechanisms in dermatomyositis, Annals of Neurology, vol.24, issue.5, pp.664-678, 2005. ,
DOI : 10.1002/ana.20464
Inclusion body myositis and myopathies, Annals of Neurology, vol.94, issue.5, pp.705-713, 1995. ,
DOI : 10.1002/ana.410380504
Inclusion body myositis and myopathies, Annals of Neurology, vol.94, issue.5, pp.705-718, 1995. ,
DOI : 10.1002/ana.410380504
BAFF and MyD88 signals promote a lupuslike disease independent of T cells, The Journal of Experimental Medicine, vol.19, issue.8, pp.1959-71, 2007. ,
DOI : 10.1126/science.1124978
Myosites : données actuelles sur la classification le diagnostic et le traitement, Rev Med Suisse, vol.4, pp.718-727, 2008. ,
Open-label trial of anti-TNF-alpha in dermato-and polymyositis treated concomitantly with methotrextate ,
Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity, Autoimmunity Reviews, vol.12, issue.2, pp.210-217, 2012. ,
DOI : 10.1016/j.autrev.2012.06.006
Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies, European Respiratory Journal, vol.37, issue.3, pp.714-721, 2011. ,
DOI : 10.1183/09031936.00104310
URL : https://hal.archives-ouvertes.fr/hal-00873290
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study, The Lancet, vol.357, issue.9250, pp.96-100, 2001. ,
DOI : 10.1016/S0140-6736(00)03540-6
Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies, Annals of Neurology, vol.5, issue.5, pp.498-507, 1991. ,
DOI : 10.1002/ana.410290509
119 th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 october, Neuromuscul Disord, vol.14, pp.337-345, 2003. ,
Use of etanercept in the treatment of dermatomyositis : a case series, J Rheumtaol, vol.33, pp.1802-1806, 2006. ,
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy, The American Journal of Medicine, vol.94, issue.4, pp.379-87, 1993. ,
DOI : 10.1016/0002-9343(93)90148-I
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology, vol.46, issue.1, pp.25-28, 2007. ,
DOI : 10.1093/rheumatology/kel161
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis, BMC Musculoskeletal Disorders, vol.49, issue.1, p.223, 2010. ,
DOI : 10.1093/rheumatology/keq153
Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy, Arthritis & Rheumatism, vol.73, issue.1, pp.209-224, 2004. ,
DOI : 10.1002/art.11484
Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis: Implications for diagnosis and therapy, Arthritis & Rheumatism, vol.103, issue.8, pp.1866-1873, 2000. ,
DOI : 10.1002/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6
Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis, New England Journal of Medicine, vol.314, issue.6, pp.329-334, 1986. ,
DOI : 10.1056/NEJM198602063140601
Tumor Necrosis Factor Inhibitor???Associated Dermatomyositis, Archives of Dermatology, vol.146, issue.7, pp.780-784, 2010. ,
DOI : 10.1001/archdermatol.2010.142
Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes, Arthritis Research & Therapy, vol.9, issue.4, p.78, 2007. ,
DOI : 10.1186/ar2276
Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis, Muscle & Nerve, vol.12, issue.1, pp.115-117, 1998. ,
DOI : 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2
Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients., Annals of the Rheumatic Diseases, vol.52, issue.12, pp.857-61, 1993. ,
DOI : 10.1136/ard.52.12.857
The clinical features, diagnosis and classification of dermatomyositis, Journal of Autoimmunity, vol.48, pp.122-127, 2014. ,
Polymyositis-Dermatomyositis and Malignant Lesions: Does an Association Exist?, Mayo Clinic Proceedings, vol.61, issue.8, pp.645-653, 1986. ,
DOI : 10.1016/S0025-6196(12)62030-8
Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis, Arthritis & Rheumatism, vol.23, issue.3, pp.328-334, 1987. ,
DOI : 10.1002/art.1780300312
Classification, Diagnosis, and Management of Idiopathic Inflammatory Myopathies, The Journal of Rheumatology, vol.40, issue.5, pp.550-64, 2013. ,
DOI : 10.3899/jrheum.120682
Classification, Diagnosis, and Management of Idiopathic Inflammatory Myopathies, The Journal of Rheumatology, vol.40, issue.5, pp.550-564, 2013. ,
DOI : 10.3899/jrheum.120682
Malignancy in adult dermatomyositis, International Journal of Dermatology, vol.36, issue.12, pp.904-907, 1997. ,
DOI : 10.1046/j.1365-4362.1997.00190.x
Paraneoplastic necrotizing myopathy: Clinical and pathologic features, Neurology, vol.50, issue.3, pp.764-771, 1998. ,
DOI : 10.1212/WNL.50.3.764
Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies, European Journal of Immunology, vol.24, issue.11, pp.2659-2663, 1994. ,
DOI : 10.1002/eji.1830241114
Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001, Internal Medicine Journal, vol.28, issue.3, pp.170-173, 2005. ,
DOI : 10.1111/j.1445-5994.2004.00764.x
Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis, Rheumatology, vol.43, issue.5, pp.603-608, 2004. ,
DOI : 10.1093/rheumatology/keh130
Dermatomyositis and polymyositis, Annals of the New York Academy of Sciences, vol.4, issue.Pt 6, pp.134-153, 2010. ,
DOI : 10.1111/j.1749-6632.2009.05119.x
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study, Archives of Internal Medicine, vol.145, issue.10, pp.1835-1839, 1985. ,
DOI : 10.1001/archinte.145.10.1835
Interstitial lung disease in polymyositis and dermatomyositis, Arthritis Care & Research, vol.26, issue.Suppl 5, pp.614-636, 2002. ,
DOI : 10.1002/art.10794
Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients, Arthritis & Rheumatism, vol.41, issue.Suppl 5 ,
DOI : 10.1002/art.30513
Influence of Age on Characteristics of Polymyositis and Dermatomyositis in Adults, Medicine, vol.78, issue.3, pp.139-147, 1999. ,
DOI : 10.1097/00005792-199905000-00001
Comparaison of long-term outcome between JO-1 and antiPL7-PL-12 positive patients with antisynthetase syndrome ,
Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients, Arthritis Care & Research, vol.10, issue.12, pp.1748-55, 2010. ,
DOI : 10.1002/acr.20325
Therapy of polymyositis and dermatomyositis, Autoimmunity Reviews, vol.11, issue.1, pp.6-13, 2011. ,
DOI : 10.1016/j.autrev.2011.06.007
Morbidity and Mortality in Adult Polymyositis and Dermatomyositis, Current Rheumatology Reports, vol.15, issue.3, pp.275-285, 2012. ,
DOI : 10.1007/s11926-012-0249-3
Pulsed intravenous methylprednisolone combined with oral steroids as the initial treatment of inflammatory myopathies., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.8, p.1008, 1994. ,
DOI : 10.1136/jnnp.57.8.1008
Incidence and prevalence of inflammatory myopathies: a systematic review, Rheumatology, vol.54, issue.1, pp.50-63, 2015. ,
DOI : 10.1093/rheumatology/keu289
The principal antinuclear and anticytoplamic antibodies in polymyositis and dermatomyositis. Study of 42 cases, Press Med, vol.16, pp.155-163, 1987. ,
Anti-vascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications, Rev Rhum (Engl Ed, vol.62, pp.737-747, 1995. ,
Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.326, issue.21, pp.1380-1384, 1992. ,
DOI : 10.1056/NEJM199205213262102
Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy, J Neurol Sci, vol.199, issue.1, p.53, 2002. ,
Mycophenolate mofetil treatment in resistant myositis, Rheumatology, vol.46, issue.3, pp.516-524, 2007. ,
DOI : 10.1093/rheumatology/kel336
Cancer-Associated Myositis: Clinical Features and Prognostic Signs, Annals of the New York Academy of Sciences, vol.144, issue.1, pp.64-71, 2005. ,
DOI : 10.1196/annals.1361.047
The geoepidemiology of autoimmune muscle disease, Autoimmunity Reviews, vol.9, issue.5, pp.330-334, 2010. ,
DOI : 10.1016/j.autrev.2009.11.006
Genetic and environmental risk factors for idiopathic inflammatory myopathies, Rheumatic Disease Clinics of North America, vol.28, issue.4, pp.891-916, 2002. ,
DOI : 10.1016/S0889-857X(02)00029-7
Immunoperoxidase Technique on Paraffin Sections Fails to Demonstrate Immunoglobulin Deposition in Cutaneous Lesions from Patients with Dermatomyositis, The American Journal of Dermatopathology, vol.10, issue.4, pp.297-299, 1988. ,
DOI : 10.1097/00000372-198808000-00003
POLYMYOSITIS: A SURVEY OF 89 CASES WITH PARTICULAR REFERENCE TO TREATMENT AND PROGNOSIS, Brain, vol.89, issue.4, pp.747-68, 1996. ,
DOI : 10.1093/brain/89.4.747
Signes pr??dictifs de cancers au cours de la dermatomyosite. ??tude de 29 observations, La Revue de M??decine Interne, vol.15, issue.1, pp.19-24, 1994. ,
DOI : 10.1016/S0248-8663(05)82125-3
Significance of MI-2 autoantibodies in polymyositis and dermatomyositis, J Rheumatol, vol.25, pp.395-396, 1998. ,
Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis, J Rheumatol, vol.31, pp.801-808, 2004. ,
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis, Arthritis & Rheumatism, vol.40, issue.5, pp.1571-1577, 2005. ,
DOI : 10.1002/art.21023
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine, Arthritis Research & Therapy, vol.14, issue.1, p.22, 2012. ,
DOI : 10.1002/art.24904
MHC Class l-Mediated Cytotoxicity Does Not Induce Apoptosis in Muscle Fibers nor in Inflammatory T Cells, Journal of Neuropathology and Experimental Neurology, vol.55, issue.12, pp.1205-1209, 1996. ,
DOI : 10.1097/00005072-199612000-00003
BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth, The Journal of Experimental Medicine, vol.85, issue.11, pp.1747-56, 1999. ,
DOI : 10.1126/science.7537388
Rituximab treatment of the anti-synthetase syndrome--a retrospective case series, Rheumatology, vol.48, issue.8, pp.968-71, 2009. ,
DOI : 10.1093/rheumatology/kep157
Update on the genetics of the idiopathic inflammatory myopathies, Current Opinion in Rheumatology, vol.12, issue.6, pp.482-491, 2000. ,
DOI : 10.1097/00002281-200011000-00002
Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis, Clinical Rheumatology, vol.23, issue.3, pp.262-267, 2004. ,
DOI : 10.1007/s10067-004-0865-z
Comment faire le diagnostic et mieux comprendre les myopathies inflammatoires??? L???utilit?? des auto-anticorps, La Presse M??dicale, vol.39, issue.10, pp.1010-1025, 2010. ,
DOI : 10.1016/j.lpm.2010.06.008
Routine vs Extensive Malignancy Search for Adult Dermatomyositis and Polymyositis, Archives of Dermatology, vol.138, issue.7, pp.885-890, 2002. ,
DOI : 10.1001/archderm.138.7.885
Antisynthetase Syndrome with Anti-Jo1 Antibodies in 48 Patients: Pulmonary Involvement Predicts Disease-modifying Antirheumatic Drug Use, The Journal of Rheumatology, vol.39, issue.9, pp.1835-1844, 2012. ,
DOI : 10.3899/jrheum.111604
Anti???Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy, Arthritis & Rheumatism, vol.169, issue.9, pp.3125-3156, 2007. ,
DOI : 10.1002/art.22865
Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality, Rheumatology, vol.41, issue.1, pp.22-28, 2002. ,
DOI : 10.1093/rheumatology/41.1.22
Mycophenolate Mofetil Is Safe, Well Tolerated, and Preserves Lung Function in Patients With Connective Tissue Disease-Related Interstitial Lung Disease, Chest, vol.130, issue.1, pp.30-36, 2006. ,
DOI : 10.1016/S0012-3692(15)50949-5
Metabolic causes of myoglobinuria, Annals of Neurology, vol.38, issue.2, pp.181-186, 1990. ,
DOI : 10.1002/ana.410270214
Serum aldolase with creatine kinase in current clinical practice, Br J Clin Prat, vol.44, pp.582-586, 1990. ,
Survival, mortality and causes of death in inflammatory myopathies, Autoimmunity, vol.125, issue.3, pp.205-215, 2006. ,
DOI : 10.1016/0049-0172(86)90014-4
Les polymyosites et dermatomyosites de l'adulte. Etude multicentrique tunisienne ,
Prise en charge th??rapeutique des polymyosites, dermatomyosites, myosites de chevauchement et myopathies n??crosantes auto-immunes, La Revue de M??decine Interne, vol.35, issue.7, pp.466-471, 2014. ,
DOI : 10.1016/j.revmed.2013.09.008
Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies, Medicine, vol.84, issue.4, pp.231-249, 2005. ,
DOI : 10.1097/01.md.0000173991.74008.b0
Analysis of 100 French Canadian Patients, Medicine, vol.84, pp.231-249, 2005. ,
Dermatopolymyositis and other connective tissue diseases: a review of 105 cases, J Rheumatol, vol.12, pp.1140-1148, 1985. ,
Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: A case series, Arthritis Care & Research, vol.44, issue.9, pp.1328-1362, 2010. ,
DOI : 10.1002/acr.20219
Polymyositis, Neurology, vol.61, issue.3 ,
DOI : 10.1212/WNL.61.3.316
Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens, Arthritis & Rheumatism, vol.270, issue.3, pp.392-401, 1998. ,
DOI : 10.1002/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X
Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study, International Journal of Dermatology, vol.89, issue.93, pp.729-734, 2002. ,
DOI : 10.1001/archderm.126.5.633
Inclusion body myositis, Lab Invest, vol.25, pp.240-248, 1972. ,
The overall and temporal association of cancer with polymyositis and dermatomyositis, J Rheumatol, vol.21, pp.1855-1864, 1994. ,
myopathies inflammatoires; polymyosites; dermatomyosites ; myopathies nécrosantes auto-immunes ; myosites à inclusions ; classifications ; auto-anticorps ,